J Coast Life Med 11:14041420 Maia VS, Berzaghi R, Arruda DC, Machado FC, Loureiro LL, Melo PM, Morais AS, Budu A, Travassos LR (2022) PLP2-derived peptide Rb4 triggers PARP-1-mediated necrotic death in murine melanoma cells
If you experience any of the following, remain at your current dose for an additional 2 to 4 weeks before escalating: Nausea lasting more than 3 days after injection Vomiting more than once per week Inability to maintain adequate caloric intake (under 1,000 calories daily) Signs of dehydration despite increased fluid intake New onset of significant fatigue that interferes with daily function Slowing escalation is not failure
However, before deciding whether to start any of these treatments, patients must be fully informed about the potential benefits, risks, and limitations
The comprehensive peptide therapy cost guide provides additional context on pricing factors and considerations
T., Kurenda, A., Stolz, S., Chetelat, A
Vande Casteele, N., Jakate, A., McNamee, B